Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new site revision note 'Revision: v3.3.3' appears in the footer, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:26:41.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2, indicating a minor page revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:50:43.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.1; there are no changes to trial details or core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:46:57.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed the government funding–related operating-status notice banner from the page. Core study content and navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T07:31:56.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The updates appear to be minor UI and layout changes to the Study Details page, with no modifications to core content like the study title, conditions, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:28:48.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:43:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.